Author: OurCrowd

[Biolojic in Startup News] Biolojic Design enters into a multi-target drug discovery collaboration with Merck KGaA, Darmstadt, Germany

Jun 3, 2024 |

Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into programmable, intelligent medicines, today announced that it has entered into a multi-target drug discovery collaboration with Merck KGaA, Darmstadt, Germany. The partnership will leverage Biolojic Design’s AI-driven discovery platform to design therapeutic antibodies for the treatment of cancer and immunological disorders. Read...

Read More

[Neuberger Berman Strategic Capital II in PEI] GP-Led Secondaries: Private Equity’s Most Underserved Market?

Jun 3, 2024 |

Over the last 12 to 18 months, we have witnessed a meaningful decline in private equity (PE) exits, which triggered an estimated $106 billion of net cash outflows for PE investors in 2022 alone.1 In our view, this dynamic—combined with the denominator effect and generally elongating holding periods—is opening attractive opportunities for providers of liquidity to the private markets. Read more...

Read More